134 related articles for article (PubMed ID: 8335852)
1. Serum eosinophil cationic protein during treatment of asthma in children.
Juntunen-Backman K; Järvinen P; Sorva R
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):34-8. PubMed ID: 8335852
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood.
Prehn A; Seger RA; Torresani T; Molinari L; Sennhauser FH
Pediatr Allergy Immunol; 2000 May; 11(2):87-94. PubMed ID: 10893010
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of monitoring eosinophil activity in asthma.
Koller DY; Herouy Y; Götz M; Hagel E; Urbanek R; Eichler I
Arch Dis Child; 1995 Nov; 73(5):413-7. PubMed ID: 8554357
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children.
Sorva R; Metso T; Turpeinen M; Juntunen-Backman K; Björksten F; Haahtela T
Pediatr Allergy Immunol; 1997 Feb; 8(1):45-50. PubMed ID: 9260219
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
6. Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment.
Aldridge RE; Hancox RJ; Cowant JO; Frampton CM; Town GI; Taylor DR
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):492-7. PubMed ID: 12452208
[TBL] [Abstract][Full Text] [Related]
7. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects.
Kuo HP; Yu TR; Yu CT
Eur Respir J; 1994 Aug; 7(8):1452-9. PubMed ID: 7957830
[TBL] [Abstract][Full Text] [Related]
8. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.
Venge P; Dahl R; Peterson CG
Int Arch Allergy Appl Immunol; 1988; 87(3):306-12. PubMed ID: 3144513
[TBL] [Abstract][Full Text] [Related]
10. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.
Vatrella A; Ponticiello A; Parrella R; Romano L; Zofra S; DiLeva A; Bariffi F
Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658
[TBL] [Abstract][Full Text] [Related]
11. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
Wever AM; Wever-Hess J; Hermans J
Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
[TBL] [Abstract][Full Text] [Related]
12. Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis.
Reijonen TM; Korppi M; Kuikka L; Savolainen K; Kleemola M; Mononen I; Remes K
Pediatr Pulmonol; 1997 Jun; 23(6):397-403. PubMed ID: 9220520
[TBL] [Abstract][Full Text] [Related]
13. Eosinophils in exercise-induced asthma.
Venge P; Henriksen J; Dahl R
J Allergy Clin Immunol; 1991 Nov; 88(5):699-704. PubMed ID: 1955630
[TBL] [Abstract][Full Text] [Related]
14. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy.
Zimmerman B; Lanner A; Enander I; Zimmerman RS; Peterson CG; Ahlstedt S
Clin Exp Allergy; 1993 Jul; 23(7):564-70. PubMed ID: 8221257
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma.
Ferguson AC; Vaughan R; Brown H; Curtis C
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):23-8. PubMed ID: 7822660
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.
Dal Negro R; Micheletto C; Tognella S; Mauroner L; Burti E; Turco P; Pomari C; Cantini L
J Investig Allergol Clin Immunol; 1999; 9(4):241-7. PubMed ID: 10513351
[TBL] [Abstract][Full Text] [Related]
17. Serum eosinophil cationic protein and bronchial hyperresponsiveness to hypoosmolar challenge in naive atopic asthmatics.
Dal Negro R; Tognella S; Micheletto C; Pomari C; Burti E; Mauroner L; Turco P
J Investig Allergol Clin Immunol; 1998; 8(5):294-9. PubMed ID: 9827426
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
19. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma.
Salome CM; Reddel HK; Ware SI; Roberts AM; Jenkins CR; Marks GB; Woolcock AJ
Am J Respir Crit Care Med; 2002 Jan; 165(1):15-21. PubMed ID: 11779724
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma.
Türktaş I; Demirsoy S; Koç E; Gökçora N; Elbeg S
Arch Dis Child; 1996 Oct; 75(4):314-8. PubMed ID: 8984917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]